Reply to Baird and Douglas

Clin Infect Dis. 2021 May 4;72(9):e436. doi: 10.1093/cid/ciaa1106.

Authors

Marc Bonten¹, Thomas Verstraeten², Stefan Gravenstein³, Jan Poolman⁴

Affiliations

¹ Julius Center, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.
² P95 Pharmacovigilance and Epidemiology Services, Leuven, Belgium.
³ Brown University and Providence Veterans Administration Hospital, Providence, Rhode Island, USA.
⁴ Bacterial Vaccine Discovery and Early Development, Janssen Vaccines and Prevention B. V., Leiden, The Netherlands.

PMID: 32756981
DOI: 10.1093/cid/ciaa1106

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Bacteremia*
Escherichia coli*
Humans
Staphylococcus aureus